Rubric Capital Management LP Arbutus Biopharma Corp Transaction History

Rubric Capital Management LP

  • $2.93 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$2.24 - $3.06 $1.79 Million - $2.45 Million
-799,217 Reduced 19.05%
3,395,855 $7.81 Million
Q1 2023

May 12, 2023
BUY
$2.23 - $3.1 $1.63 Million - $2.26 Million
728,791 Added 21.03%
4,195,072 $12.7 Million
Q4 2022

Feb 10, 2023
BUY
$1.91 - $2.85 $6.62 Million - $9.88 Million
3,466,281 New
3,466,281 $8.08 Million

Others Institutions Holding ABUS

# of Institutions
130
Shares Held
82.2M
Call Options Held
4.82M
Put Options Held
546K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $468M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email